Results for tag: "Testis Cancer"

Testis cancer is a type of cancer that affects the testicles, which are part of the male reproductive system. It is the most common cancer in men aged 15-35 and is usually curable if detected early. Treatment options for testis cancer include surgery, radiation therapy, chemotherapy, and targeted therapy. Surgery is the most common treatment and involves removing the affected testicle. Radiation therapy and chemotherapy are used to kill any remaining cancer cells. Targeted therapy is used to block the growth of cancer cells. Testis cancer is a relatively rare form of cancer, accounting for only 1% of all cancers in men. However, it is the most common cancer in young men and is the most common cause of cancer death in men aged 15-35. There are several companies in the testis cancer market, including AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and marketing of drugs and treatments for testis cancer. Show Less Read more